FindTrial
Sign In

A prospective cohort study comparing the treatable traits of different clinical phenotypes of bronchiectasis

A prospective cohort study comparing the therapeutic properties of different clinical phenotypes of bronchiectasis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040798
Enrollment
Unknown
Registered
2020-12-10
Start date
2019-09-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

frequent exacerbator phenotype:non
frenon-quent exacerbator phenotype:non
pseudomonas aeruginosa colonization:non- pseudomonas aeruginosa colonization

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 136 bronchiectatci patients diagnosized by HRCT and admitted to the PCCM unit of Shenzhen Second People's Hospital from Jan,2020 to Dec 2021 for acute apisode of bronchiectasis,of which with at least one of the four symptoms including more cough,phlegm,shortness of breath and wheezing more than the usual level so that hospitalization is necessary.

Exclusion criteria

Exclusion criteria: Bronchiectatic patients with milignant tumors,psychiatric illness and HIV positivity ,pregnant women and under-age patients are exclued.

Design outcomes

Primary

MeasureTime frame
Aspergillosis-spicific IgG;Aspergillosis-spicific IgE;sputum culture;serum total IgE;—

Secondary

MeasureTime frame
vitamin D3;interliukin 6;ANA;ANCA;—

Countries

China

Contacts

Public ContactHe Huang

Shenzhen Second People's Hospital

hehuang0822@163.com+8613751003821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026